Candesartan Fails to Alter Tau Pathology in Transgenic Mouse Model
A preclinical study found that six weeks of candesartan administration did not modify tau pathology, receptor levels, or neuroinflammatory markers ...
Tag: immunoblotting
A preclinical study found that six weeks of candesartan administration did not modify tau pathology, receptor levels, or neuroinflammatory markers ...
